Abstract
Myotonic dystrophy type 1 (DM1) is caused by a CTG trinucleotide expansion in the 3′ untranslated region of the DM protein kinase gene. People with DM1 have an unusual form of insulin resistance caused by a defect in skeletal muscle. Here we demonstrate that alternative splicing of the insulin receptor (IR) pre-mRNA is aberrantly regulated in DM1 skeletal muscle tissue, resulting in predominant expression of the lower-signaling nonmuscle isoform (IR-A). IR-A also predominates in DM1 skeletal muscle cultures, which exhibit a decreased metabolic response to insulin relative to cultures from normal controls. Steady-state levels of CUG-BP, a regulator of pre-mRNA splicing proposed to mediate some aspects of DM1 pathogenesis, are increased in DM1 skeletal muscle; overexpression of CUG-BP in normal cells induces a switch to IR-A. The CUG-BP protein mediates this switch through an intronic element located upstream of the alternatively spliced exon 11, and specifically binds within this element in vitro. These results support a model in which increased expression of a splicing regulator contributes to insulin resistance in DM1 by affecting IR alternative splicing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fu, Y.H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256–1258 (1992).
Mahadevan, M. et al. Myotonic dystrophy mutation—an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255, 1253–1255 (1992).
Brook, J.D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799–808 (1992).
Wang, J. et al. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 4, 599–606 (1995).
Tapscott, S.J. Deconstructing myotonic dystrophy. Science 289, 1701–1702 (2000).
Mankodi, A. et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769–1773 (2000).
Timchenko, L.T. Myotonic dystrophy: the role of RNA CUG triplet repeats. Am. J. Hum. Genet. 64, 360–364 (1999).
Miller, J.W. et al. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J. 19, 4439–4448 (2000).
Ladd, A.N., Charlet-B., N. & Cooper, T.A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21, 1285–1296 (2001).
Roberts, R. et al. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl Acad. Sci. USA 94, 13221–13226 (1997).
Philips, A.V., Timchenko, L.T. & Cooper, T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737–741 (1998).
Moxley, R.T., Corbett, A.J., Minaker, K.L. & Rowe, J.W. Whole body insulin resistance in myotonic dystrophy. Ann. Neurol. 15, 157–162 (1984).
Moxley, R.T. III et al. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J. Clin. Invest. 62, 857–867 (1978).
Vialettes, B. et al. Mechanism and significance of insulin resistance in myotonic dystrophy. Horm. Metab. Res. 18, 395–399 (1986).
Moller, D.E., Yokota, A., Caro, J.F. & Flier, J.S. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol. Endocrinol. 3, 1263–1269 (1989).
Seino, S. & Bell, G.I. Alternative splicing of human insulin receptor messenger RNA. Biochem. Biophys. Res. Commun. 159, 312–316 (1989).
Mosthaf, L. et al. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J. 9, 2409–2413 (1990).
McClain, D.A. Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol. Endocrinol. 5, 734–739 (1991).
Vogt, B., Carrascosa, J.M., Ermel, B., Ullrich, A. & Häring, H.-U. The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem. Biophys. Res. Commun. 177, 1013–1018 (1991).
Kellerer, M. et al. Distinct α-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities. Biochemistry 31, 4588–4596 (1992).
Kosaki, A. & Webster, N.J.G. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J. Biol. Chem. 268, 21990–21996 (1993).
Kosaki, A., Pillay, T.S., Xu, L. & Webster, N.J.G. The B isoform of the insulin receptor signals more efficiently than the A isoform in HepG2 cells. J. Biol. Chem. 270, 20816–20823 (1995).
Leibiger, B. et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells. Mol. Cell 7, 559–570 (2001).
Morrone, A. et al. RNA metabolism in myotonic dystrophy—patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. J. Clin. Invest. 99, 1691–1698 (1997).
Furling, D., Marette, A. & Puymirat, J. Insulin-like growth factor I circumvents defective insulin action in human myotonic dystrophy skeletal muscle cells. Endocrinology 140, 4244–4250 (1999).
Kellerer, M. et al. Altered pattern of insulin receptor isotypes in skeletal muscle membranes of type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 36, 628–632 (1993).
Benecke, H., Flier, J.S. & Moller, D.E. Alternatively spliced variants of the insulin receptor protein. Expression in normal and diabetic human tissues. J. Clin. Invest. 89, 2066–2070 (1992).
DePirro, R. et al. Decreased insulin receptors but normal glucose metabolism in Duchenne muscular dystrophy. Science 216, 311–313 (1982).
Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. & Housman, D.E. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA 94, 7388–7393 (1997).
Otten, A.D. & Tapscott, S.J. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Nat. Acad. Sci.USA 92, 5465–5469 (1995).
Klip, A. & Leiter, L.A. Cellular mechanism of action of metformin. Diabetes Care 13, 696–704 (1990).
Kosaki, A., Nelson, J. & Webster, N.J.G. Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA. J. Biol. Chem. 273, 10331–10337 (1998).
DeFronzo, R.A. et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000–1007 (1981).
Frasca, F. et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol. 19, 3278–3288 (1999).
Timchenko, N.A., Welm, A.L., Lu, X. & Timchenko, L.T. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPβ mRNA and regulates translation of C/EBPβ isoforms. Nucleic Acids Res. 27, 4517–4525 (1999).
Timchenko, N.A. et al. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 276, 7820–7826 (2001).
Korade-Mirnics, Z. et al. Myotonic dystrophy: tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression. Hum. Mol. Genet. 8, 1017–1023 (1999).
Weintraub, H. et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl Acad. Sci. USA 86, 5434–5438 (1989).
Sarabia, V., Lam, L., Burdett, E., Leiter, L.A. & Klip, A. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J. Clin. Invest. 90, 1386–1395 (1992).
Acknowledgements
We thank C. Thornton, J. Day, H. Vogel, Z. Korade-Mirnics, E. Hoffman, E. Pegoraro, S. Servidei, C. Angelini, the University of Miami Brain and Tissue Bank (N01-HD-8-3284), CHTN, and Midwestern and Southern Divisions for tissue samples; K. Hess for help with statistical analysis; D. Miller for the MyoD/NeoR amphotrophic retrovirus; M. Swanson for antibody to CUG-BP; P. Anderson for cTNT antibody; S. Hauschka and S. Tapscott for advice on converting fibroblast cultures; L. Timchenko for RNA samples and a normal fibroblast culture; N. Webster for IR minigene constructs; and A. Ladd, N. Charlet-B., C. Thornton, J. Day, N. Webster, and K. Mihindukulasuriya for comments on the manuscript. This work was supported by NIH (R01AR45653) and the Muscular Dystrophy Association (T.A.C.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Savkur, R., Philips, A. & Cooper, T. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29, 40–47 (2001). https://doi.org/10.1038/ng704
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng704
This article is cited by
-
Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review
Cellular & Molecular Biology Letters (2024)
-
Afterdischarges in myotonic dystrophy type 1
Neurological Sciences (2024)
-
Caenorhabditis elegans ETR-1/CELF has broad effects on the muscle cell transcriptome, including genes that regulate translation and neuroblast migration
BMC Genomics (2022)
-
Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats
Nature Biomedical Engineering (2022)
-
miR-322/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats
Cell Death & Disease (2020)